A Phase 3, Multicenter, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study of Cyclosporin Ophthalmic Gel in Subjects with Moderate to Severe Dry Eye Disease
Latest Information Update: 21 Jan 2025
Price :
$35 *
At a glance
- Drugs Ciclosporin (Primary)
- Indications Dry eyes
- Focus Registrational; Therapeutic Use
- Sponsors Zhaoke Guangzhou Ophthalmology Pharmaceutical
- 15 Jan 2025 New trial record